🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test whether vaccination with antigenic pep...
Status
Completed
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Start Date
1999-05
Trial ID
NCT00112216
Treatments Being Tested
RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1997-04
Trial ID
NCT00019214
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1999-10
Trial ID
NCT00019994
Treatments Being Tested
RATIONALE: Diagnostic procedures that analyze surgically-removed tumor tiss...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2002-09
Trial ID
NCT00049010
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Surgery Branch
Start Date
1999-04
Trial ID
NCT00019721
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludara...
Status
Completed
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2005-09
Trial ID
NCT00324623
RATIONALE: Inserting a laboratory-treated gene into a person's white blood ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-07
Trial ID
NCT00091104
Treatments Being Tested
This randomized phase II trial is studying how well giving vaccine therapy ...
Status
Terminated
Location
National Cancer Institute Surgery Branch
Start Date
2005-11
Trial ID
NCT00303836
Background: * Melanoma antigen recognized by T-cells (MART-1) and gp100 ar...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2008-12
Trial ID
NCT00923195